Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV001509138 | SCV001715688 | likely pathogenic | not provided | 2019-04-25 | criteria provided, single submitter | clinical testing | PS3, PM1, PM2, PP4 |
Dunham Lab, |
RCV002305610 | SCV002599212 | likely pathogenic | Anemia, nonspherocytic hemolytic, due to G6PD deficiency | 2022-08-12 | criteria provided, single submitter | curation | Variant alters substrate binding site (PM1) and leads to decreased activity when expressed in S. cerevisiae (PS3_M). Below expected carrier frequency in gnomAD (PM2). Post_P 0.900 (odds of pathogenicity 81.2, Prior_P 0.1). |